Pune, India -- (SBWire) -- 03/02/2019 --ReportsnReports always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the global Cell Therapy Technologies Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy of "Cell Therapy Technologies Market" at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1824086
The Global Cell Therapy Instruments Market is projected to reach US$ 19.9 Billion by 2023 from US$ 10.2 Billion in 2018, at a CAGR of 14.4% during the forecast period. Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market.
Top Key Players in the "Cell Therapy Technologies Market" include are
- Beckman Coulter (US)
- Becton Dickinson and Company (US)
- GE Healthcare (US)
- Lonza (Switzerland)
- Merck KGaA (Germany)
- Miltenyi Biotec (Germany)
- STEMCELL Technologies Inc. (Canada)
- Terumo BCT (US)
- Thermo Fisher Scientific (US)
Access Complete report on Cell Therapy Technologies Market spread across 116 Pages, profiling 10 companies and supported with tables and figures. Buy Research at https://www.reportsnreports.com/purchase.aspx?name=1824086
"Cell processing segment dominates the cell therapy instruments market during the forecast period"
Based on process, the cell therapy instruments market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest share of the market in 2018 and is expected to grow at the highest CAGR during the forecasted period.
"North America to command the largest share of the cell therapy instruments market in 2018"
The Cell Therapy Instruments Market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest market share in 2018. The increasing R&D activities in the pharmaceutical and biotechnology industries is one of the major factors driving the demand for cell therapy instruments in North America during the forecast period.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
- By Designation: C-level - 30%, Director-level - 20%, and Others - 50%
- By Region: North America - 35%, Europe - 24%, Asia Pacific - 25%, and the RoW - 16%
Reason to Buy this report:
- Market Penetration: Comprehensive information on cell therapy instruments offered by the top 10 players in the global cell therapy instruments market. The report analyzes the cell therapy instruments market by product, cell type, end user, process stage, and region
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell therapy instruments across key regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global cell therapy instruments market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the global cell therapy instruments market
Cell Therapy Technologies Market to Reach US$ 19.9 Billion Growing at CAGR 14.4% to 2023
Cell Therapy Technologies Market 2018-2023 report tells the market value in Next Few Years and report shows the whole scenario of Cell Therapy Technologies industry.